Sangamo Therapeutics, Inc. (SGMO)
NASDAQ: SGMO · Real-Time Price · USD
0.4754
-0.0237 (-4.75%)
May 21, 2025, 1:44 PM - Market open
Sangamo Therapeutics Employees
Sangamo Therapeutics had 183 employees as of December 31, 2024. The number of employees decreased by 222 or -54.81% compared to the previous year.
Employees
183
Change (1Y)
-222
Growth (1Y)
-54.81%
Revenue / Employee
$348,393
Profits / Employee
-$434,148
Market Cap
112.95M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
SGMO News
- 8 days ago - Sangamo Therapeutics, Inc. (SGMO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2025 Financial Results - Business Wire
- 8 days ago - Sangamo Therapeutics Announces Pricing of $23.0 Million Underwritten Offering - Business Wire
- 8 days ago - Sangamo Therapeutics Postpones First Quarter 2025 Conference Call to Later the Same Day - Business Wire
- 14 days ago - Sangamo Therapeutics Announces First Quarter 2025 Earnings Call - Business Wire
- 15 days ago - Sangamo Therapeutics Announces Important Derisking Milestones in Pathway to Anticipated BLA Submission for ST-920 in Fabry Disease - Business Wire
- 22 days ago - Sangamo Therapeutics to Present Neurology Pipeline Advances at the 28th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) - Business Wire
- 6 weeks ago - Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal - Seeking Alpha